Managing Revenue Decline for Pharmaceutical Brands

There is still opportunity to improve the bottom-line contribution made by pharmaceutical brands with declining sales revenue. Slowing the rate of decline can often provide a tremendous return on investment for savvy pharmaceutical marketing teams. Prior to going generic, many brands are faced with declining share of voice due to reduced marketing budgets and sales force reallocation.

The multichannel marketing and messaging capabilities provided by PharmaKinnex can help to offset lost sales and marketing resources. Our cost effective, highly measurable programs are proven to deliver pinpoint messages via a target’s favorite communication channels. In the decline phase, when resources are limited, multichannel marketing offers:

• The reach and frequency to offset the decline in share of voice
• Smart Sampling programs to keep your brand front and center as prescriptions are written.